This condition can affect various areas of the body and produce multiple symptoms. Vasculitis symptoms include rash, body aches or discomfort, decreased appetite, fatigue, and fever—among others.

Healthy lifestyle choices can help to prevent vasculitis from happening. The symptoms of vasculitis vary depending on the type and the part of the body affected. There can be a rash, which may look ...

The presence of a hypertensive emergency may be a sign of ANCA-associated vasculitis. In Cureus, physicians reported the case of a patient ... as well as the presence of pinpoint superficial pruritic ...

AstraZeneca's Fasenra (benralizumab) has been approved in the US for the treatment of adult patients with eosinophilic ...

Withhold TAGRISSO if EMM, SJS, or TEN is suspected and permanently discontinue if confirmed Postmarketing cases of cutaneous vasculitis including leukocytoclastic vasculitis, urticarial vasculitis, ...

EU committee recommends approval of AstraZeneca’s Fasenra to treat eosinophilic granulomatosis with polyangiitis: Cambridge, UK Tuesday, September 24, 2024, 09:00 Hrs [IST] Astr ...

Detailed results from the TROPION-Lung01 Phase III trial showed a clinically meaningful trend toward improving overall survival (OS) with datopotamab ...

AstraZeneca's Fasenra (benralizumab) has been approved by the US FDA for the treatment of eosinophilic granulomatosis with ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced long-term overall survival (OS) data ...

AstraZeneca’s FASENRA® (benralizumab) has been approved in the US for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA).1 EGPA is a rare, immune-mediated ...

Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma who are candidates for systemic therapy, ...